Introduction：Basic information about CAS 1007882-23-6|HCV-IN-30, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | HCV-IN-30 |
|---|
| CAS Number | 1007882-23-6 | Molecular Weight | 624.772 |
|---|
| Density | 1.2±0.1 g/cm3 | Boiling Point | 890.2±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C36H44N6O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 492.2±34.3 °C |
|---|
Names
| Name | di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
|---|
| Synonym | More Synonyms |
|---|
HCV-IN-30 BiologicalActivity
| Description | HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC50s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively[1]. |
|---|
| Related Catalog | Signaling Pathways >>Anti-infection >>HCVResearch Areas >>Infection |
|---|
| References | [1]. Belema M, et al. Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons. J Med Chem. 2014 Mar 13;57(5):1995-2012. |
|---|
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|
| Boiling Point | 890.2±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C36H44N6O4 |
|---|
| Molecular Weight | 624.772 |
|---|
| Flash Point | 492.2±34.3 °C |
|---|
| Exact Mass | 624.342407 |
|---|
| PSA | 116.44000 |
|---|
| LogP | 5.69 |
|---|
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.600 |
|---|
| InChIKey | WPMTYMFNINZZHE-KYJUHHDHSA-N |
|---|
| SMILES | CC(C)(C)OC(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)OC(C)(C)C)[nH]4)cc3)cc2)[nH]1 |
|---|
Synonyms
| Bis(1,1-dimethylethyl) (2,2'-[[1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl)]bis(1-pyrrolidinecarboxylate) |
| Daclatasvir intermediate |
| Di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
| di-tert-butyl(2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
| T5NTJ AVOX1&1&1 B- BT5M CNJ ER DR D- ET5M CNJ B- BT5NTJ AVOX1&1&1 &&(2S,2S'- Form |
| Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) |
| 1-Pyrrolidinecarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl)]bis-, bis(1,1-dimethylethyl) ester, (2S,2'S)- |
| di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(lH-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
| (2S,2'S)-DI-TERT-BUTYL-2,2'-(4,4'-([1,1'-BIPHENYL]-4,4'-DIYL - )BIS(1H-IMIDAZOLE-4,2-DIYL))BIS(PYRROLIDINE-1-CARBOXYLATE) |
